RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Waldemar Popik to Interferons

This is a "connection" page, showing publications Waldemar Popik has written about Interferons.
Connection Strength

0.515
  1. Taylor HE, Khatua AK, Popik W. The innate immune factor apolipoprotein L1 restricts HIV-1 infection. J Virol. 2014 Jan; 88(1):592-603.
    View in: PubMed
    Score: 0.116
  2. Popik W, Pitha PM. Inhibition by interferon of herpes simplex virus type 1-activated transcription of tat-defective provirus. Proc Natl Acad Sci U S A. 1991 Nov 01; 88(21):9573-7.
    View in: PubMed
    Score: 0.101
  3. Zielinska-Jenczylik J, Inglot AD, Inglot O, Popik W. Transforming growth factor-beta inhibits the antiviral action of interferons in human embryonic fibroblasts. J Interferon Res. 1991 Apr; 11(2):87-9.
    View in: PubMed
    Score: 0.097
  4. Popik W, Inglot AD. Combined action of interferons and transforming growth factor beta on the proliferation of human fibroblasts. Arch Immunol Ther Exp (Warsz). 1991; 39(1-2):19-26.
    View in: PubMed
    Score: 0.095
  5. Popik W, Inglot AD. Interactions of interferons and transforming growth factors during clonal growth of mouse or human cells in soft agar and in mice. Int J Cancer. 1987 Jul 15; 40(1):108-13.
    View in: PubMed
    Score: 0.075
  6. Shirazi Y, Popik W, Pitha PM. Modulation of interferon-mediated inhibition of human immunodeficiency virus type 1 by Tat. J Interferon Res. 1994 Oct; 14(5):259-63.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support